[HTML][HTML] Comparison of clinical outcomes with left unilateral and sequential bilateral Transcranial Magnetic Stimulation (TMS) treatment of major depressive disorder in …
Background It has been suggested that sequential bilateral (SBL) TMS, combining high
frequency, left dorsolateral prefrontal cortex (DLPFC) stimulation and low frequency, right …
frequency, left dorsolateral prefrontal cortex (DLPFC) stimulation and low frequency, right …
Augmentation in depression: Esketamine, a new standard?
JD Rosenblat, RS McIntyre - Med, 2023 - cell.com
While new add-on treatments have been developed for augmentation in depression with
benefits demonstrated compared to placebo, none have demonstrated superiority compared …
benefits demonstrated compared to placebo, none have demonstrated superiority compared …
Combinación de antidepresivos vs. aumentación con antipsicóticos atípicos tras no lograr la remisión en la depresión unipolar
R Philippi, R Correa - Revista chilena de neuro-psiquiatría, 2022 - SciELO Chile
Introducción: Lograr la recuperación funcional lo más rápido posible en el tratamiento de la
depresión unipolar es un reto que la práctica clínica debe tratar de afrontar en la actualidad …
depresión unipolar es un reto que la práctica clínica debe tratar de afrontar en la actualidad …
Predictability of nonremitting depression after first 2 weeks of antidepressant treatment: a VAST-D trial report
PB Hicks, V Sevilimedu, GR Johnson… - … and clinical practice, 2019 - Am Psychiatric Assoc
Objective: In this secondary analysis of data from the Veterans Affairs Augmentation and
Switching Treatments for Improving Depression Outcomes (VAST-D) study, the authors …
Switching Treatments for Improving Depression Outcomes (VAST-D) study, the authors …
Effect of aripiprazole on promoting cognitive function and enhancing clinical efficacy in patients with first-episode depression on escitalopram: A randomized …
Y Wang, Z Lu, G Xun - Journal of Affective Disorders, 2024 - Elsevier
Objectives To explore the effect of escitalopram combined with aripiprazole on cognitive
function in patients with major depressive disorder (MDD), and to evaluate the clinical …
function in patients with major depressive disorder (MDD), and to evaluate the clinical …
Use of psychotropic medication in women with psychotic disorders at menopause and beyond
MV Seeman, A González-Rodríguez - Current Opinion in …, 2018 - journals.lww.com
A major implication for research is that antipsychotic drugs with a wider range of action and
with fewer side effects are urgently needed. The clinical implications of the pharmacotherapy …
with fewer side effects are urgently needed. The clinical implications of the pharmacotherapy …
Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic …
M Ji, J Feng, G Liu - Plos one, 2024 - journals.plos.org
Objectives To report the first and largest systematic review and meta-analysis of randomized
controlled trials (RCT) to evaluate the efficacy and safety of aripiprazole or bupropion …
controlled trials (RCT) to evaluate the efficacy and safety of aripiprazole or bupropion …
Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial
M Takeshima, A Umakoshi, Y Omori, K Yoshizawa… - …, 2024 - Springer
Rationale The efficacy and safety of antidepressant augmentation therapy with aripiprazole
(AATA) has been established; however, the ongoing effects of continuing aripiprazole after …
(AATA) has been established; however, the ongoing effects of continuing aripiprazole after …
[PDF][PDF] Prescription réfléchie pour les patients souffrant d'une dépression difficile à traiter
A Soubolsky, J Visentin, A Crawley - Canadian Family Physician, 2023 - cfp.ca
Amy Soubolsky BSP MSc Jessica Visentin PharmD ACPR Alex Crawley BSP ACPR Le
trouble dépressif majeur est très courant. Chaque année, environ 1 Canadien sur 20 en …
trouble dépressif majeur est très courant. Chaque année, environ 1 Canadien sur 20 en …
Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder
O Köhler-Forsberg, ER Larsen… - The British Journal of …, 2019 - cambridge.org
BackgroundFor patients with major depressive disorder (MDD) experiencing side-effects or
non-response to their first antidepressant, little is known regarding the effect of switching …
non-response to their first antidepressant, little is known regarding the effect of switching …